Market Overview:
The Global Leakage ELISA Kit Market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for leakage ELISA kits for diagnostics and research purposes. The direct ELISA kit segment is expected to hold the largest share of the global leakage ELISA kit market in 2018, owing to its high accuracy and sensitivity. However, the sandwich ELISA kit segment is projected to grow at a higher CAGR during the forecast period, due to its ability detect low-level leaks in systems under test. Hospitals and clinics are expected to be the largest users of leakage ELISA kits in 2018, followed by research institutions and bio science companies.
Product Definition:
Leakage ELISA kit is a diagnostic tool used to detect and measure the amount of leakage from blood vessels. The kit is important for diagnosing and monitoring diseases that affect blood vessel function, such as hypertension and diabetes.
Direct ELISA:
Direct ELISA is a new technology that involves an antibody-antigen interaction without the need for any secondary detection antibody. It helps in detecting low abundant or rare biomarkers with high sensitivity and specificity. Direct ELISA has several advantages such as it does not use indirect methods of detection, it can be used on samples that are difficult to analyze, and it provides results within a few minutes.
Sandwich ELISA:
Sandwich ELISA is an assay that consists of two antibodies sandwiching the antigen of interest. The technique allows for the detection and quantification of analytes in a sample by utilizing both optical properties and binding properties of the antibody.
The global market for sandwich elisa kits was valued at over USD 648 million in 2013.
Application Insights:
The others segment dominated the market in terms of revenue share in 2017. This is attributed to the presence of prominent players such as Merck Millipore andMillennium Pharmaceuticals that offer a wide range of leakage testing solutions for various applications including research institutes, hospitals & clinics, and biopharmaceutical companies.
In addition, several other manufacturers have entered into partnerships with reputed international clinical diagnostic laboratories to offer high quality service across the globe. For instance, in November 2016; Roche collaborated with Ortho-Clinical Diagnostics to expand its footprint globally by offering a full range of point-of-care diagnostics for viral hepatitis infection through an extensive network of accredited laboratory facilities. Such initiatives by key industry players are expected to drive growth over the forecast period.
Hospitals & clinics were estimated as one of the largest application segments owing to increasing prevalence rates for various chronic diseases such as cancer.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The region is expected to maintain its dominance during the forecast period owing to increasing R&D activities and presence of major pharmaceutical companies. In addition, high prevalence of chronic diseases and availability of advanced therapies are some other factors driving regional market growth.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period due to rising healthcare expenditure by governments as well as private sectors in order to improve healthcare facilities at a domestic level coupled with growing awareness regarding disease diagnosis & treatment options. Moreover, increasing investments by various organizations for developing diagnostic technologies will drive regional market growth further. For instance, Novo Nordisk has invested around USD X million from 2011 till 2016 on research pertaining specifically on leaky gut syndrome which resulted into better treatments for patients suffering from this condition thus boosting industry growth in Asia Pacific region (Kumar et al., 2018).
Growth Factors:
- Increasing demand for early diagnosis of diseases
- Rising prevalence of chronic diseases
- Technological advancements in ELISA kits
- Growing awareness about Leakage ELISA Kit tests among people
- Increasing funding for research and development of Leakage ELISA Kit
Scope Of The Report
Report Attributes
Report Details
Report Title
Leakage ELISA Kit Market Research Report
By Type
Direct ELISA, Sandwich ELISA, Indirect ELISA, Competitive ELISA
By Application
Hospitals and Clinics, Research Institutions, Bio Science Companies, Others
By Companies
R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, Abcam, ALPCO, Enzo Life Sciences, BioMerieux, EMD Millipore, BioLegend, LOEWE Biochemica, Mercodia, Cusabio, Shanghai Kehua Bio-engineering
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
172
Number of Tables & Figures
121
Customization Available
Yes, the report can be customized as per your need.
Global Leakage ELISA Kit Market Report Segments:
The global Leakage ELISA Kit market is segmented on the basis of:
Types
Direct ELISA, Sandwich ELISA, Indirect ELISA, Competitive ELISA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Research Institutions, Bio Science Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- R&D Systems
- Thermo Fisher Scientific
- Ortho Clinical Diagnostics
- BD Biosciences
- ZEUS Scientific
- Bio-Rad Laboratories
- Abcam
- ALPCO
- Enzo Life Sciences
- BioMerieux
- EMD Millipore
- BioLegend
- LOEWE Biochemica
- Mercodia
- Cusabio
- Shanghai Kehua Bio-engineering
Highlights of The Leakage ELISA Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Direct ELISA
- Sandwich ELISA
- Indirect ELISA
- Competitive ELISA
- By Application:
- Hospitals and Clinics
- Research Institutions
- Bio Science Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Leakage ELISA Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Leakage ELISA Kit is a diagnostic tool used to detect the presence of leakage in a biological sample.
Some of the major companies in the leakage elisa kit market are R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, Abcam, ALPCO, Enzo Life Sciences, BioMerieux, EMD Millipore, BioLegend, LOEWE Biochemica, Mercodia, Cusabio, Shanghai Kehua Bio-engineering.
The leakage elisa kit market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Leakage ELISA Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Leakage ELISA Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Leakage ELISA Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Leakage ELISA Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Leakage ELISA Kit Market Size & Forecast, 2018-2028
4.5.1 Leakage ELISA Kit Market Size and Y-o-Y Growth
4.5.2 Leakage ELISA Kit Market Absolute $ Opportunity
Chapter 5 Global Leakage ELISA Kit Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Leakage ELISA Kit Market Size Forecast by Type
5.2.1 Direct ELISA
5.2.2 Sandwich ELISA
5.2.3 Indirect ELISA
5.2.4 Competitive ELISA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Leakage ELISA Kit Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Leakage ELISA Kit Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Research Institutions
6.2.3 Bio Science Companies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Leakage ELISA Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Leakage ELISA Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Leakage ELISA Kit Analysis and Forecast
9.1 Introduction
9.2 North America Leakage ELISA Kit Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Leakage ELISA Kit Market Size Forecast by Type
9.6.1 Direct ELISA
9.6.2 Sandwich ELISA
9.6.3 Indirect ELISA
9.6.4 Competitive ELISA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Leakage ELISA Kit Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Research Institutions
9.10.3 Bio Science Companies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Leakage ELISA Kit Analysis and Forecast
10.1 Introduction
10.2 Europe Leakage ELISA Kit Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Leakage ELISA Kit Market Size Forecast by Type
10.6.1 Direct ELISA
10.6.2 Sandwich ELISA
10.6.3 Indirect ELISA
10.6.4 Competitive ELISA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Leakage ELISA Kit Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Research Institutions
10.10.3 Bio Science Companies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Leakage ELISA Kit Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Leakage ELISA Kit Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Leakage ELISA Kit Market Size Forecast by Type
11.6.1 Direct ELISA
11.6.2 Sandwich ELISA
11.6.3 Indirect ELISA
11.6.4 Competitive ELISA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Leakage ELISA Kit Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Research Institutions
11.10.3 Bio Science Companies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Leakage ELISA Kit Analysis and Forecast
12.1 Introduction
12.2 Latin America Leakage ELISA Kit Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Leakage ELISA Kit Market Size Forecast by Type
12.6.1 Direct ELISA
12.6.2 Sandwich ELISA
12.6.3 Indirect ELISA
12.6.4 Competitive ELISA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Leakage ELISA Kit Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Research Institutions
12.10.3 Bio Science Companies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Leakage ELISA Kit Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Leakage ELISA Kit Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Leakage ELISA Kit Market Size Forecast by Type
13.6.1 Direct ELISA
13.6.2 Sandwich ELISA
13.6.3 Indirect ELISA
13.6.4 Competitive ELISA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Leakage ELISA Kit Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Research Institutions
13.10.3 Bio Science Companies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Leakage ELISA Kit Market: Competitive Dashboard
14.2 Global Leakage ELISA Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 R&D Systems
14.3.2 Thermo Fisher Scientific
14.3.3 Ortho Clinical Diagnostics
14.3.4 BD Biosciences
14.3.5 ZEUS Scientific
14.3.6 Bio-Rad Laboratories
14.3.7 Abcam
14.3.8 ALPCO
14.3.9 Enzo Life Sciences
14.3.10 BioMerieux
14.3.11 EMD Millipore
14.3.12 BioLegend
14.3.13 LOEWE Biochemica
14.3.14 Mercodia
14.3.15 Cusabio
14.3.16 Shanghai Kehua Bio-engineering
